{
  "data": [
    [
      "ZOX-0000001",
      "Migalastat",
      "DGJ HCl, Migalastat Hydrochloride, Galafold",
      "Dose-Response Complete.",
      "1000",
      ">1000",
      ">1000",
      ">1000",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O",
      "199.63"
    ],
    [
      "ZOX-0000002",
      "Midostaurin",
      "Rydapt",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "51.3",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1",
      "570.649"
    ],
    [
      "ZOX-0000003",
      "Indomethacin",
      "Indometacin",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      "587",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O",
      "357.787"
    ],
    [
      "ZOX-0000004",
      "Metformin HCl",
      "Dimethylbiguanid, Fortamet, Glucophage, Glumetza",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">1000",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "CN(C)C(=N)NC(N)=N",
      "165.62"
    ],
    [
      "ZOX-0000005",
      "Ribavirin",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "223",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O",
      "244.2"
    ],
    [
      "ZOX-0000006",
      "Mycophenolic Acid",
      "Mycophenolate mofetil",
      "Initial antiviral complete. Not progressing further.",
      "0.1",
      ">0.1",
      "nan",
      "1.77",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "COC1=C(C\\C=C(/C)CCC(O)=O)C(O)=C2C(=O)OCC2=C1C",
      "320.34"
    ],
    [
      "ZOX-0000007",
      "Melatonin",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Plaque Assay",
      "nan",
      "COC1=CC=C2NC=C(CCNC(C)=O)C2=C1",
      "232.28"
    ],
    [
      "ZOX-0000008",
      "Valproic Acid",
      "Depakene, Stavzor, Depacon",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">1000",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "CCCC(CCC)C(O)=O",
      "144.21"
    ],
    [
      "ZOX-0000009",
      "Entacapone",
      "Comtan",
      "Initial antiviral complete. Identified for further screening.",
      "100",
      "nan",
      "nan",
      "232",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "CCN(CC)C(=O)C(=C\\C1=CC(=C(O)C(O)=C1)[N+]([O-])=O)\\C#N",
      "305.29"
    ],
    [
      "ZOX-0000010",
      "Verapamil",
      "S-verapamil",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "96.9",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1",
      "491.06"
    ],
    [
      "ZOX-0000011",
      "Haloperidol",
      "Haldol, Serenace",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      "271",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1",
      "375.86"
    ],
    [
      "ZOX-0000012",
      "(D)-PDMP",
      "N-[(1R,2R)-2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]-decanamide",
      "Initial antiviral complete. Identified for further screening.",
      "10",
      ">10",
      "nan",
      ">10",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "CCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)c2ccccc2",
      "427.02"
    ],
    [
      "ZOX-0000013",
      "U18666a",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "0.202",
      ">0.202",
      "nan",
      "7.28",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "CCN(CC)CCO[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CCC4=O)[C@@H]3CC=C2C1",
      "423.06"
    ],
    [
      "ZOX-0000014",
      "Lucerastat",
      "NB-DGJ",
      "Dose-Response Complete.",
      "100",
      "316",
      "1180",
      ">1000",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "CCCCN1C[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO",
      "219.28"
    ],
    [
      "ZOX-0000015",
      "Conduritol-B-epoxide",
      "CBE",
      "Dose-Response Complete.",
      "200",
      ">200",
      ">200",
      ">200",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "O[C@H]1[C@H](O)[C@@H](O)[C@@H]2O[C@@H]2[C@@H]1O",
      "162.1"
    ],
    [
      "ZOX-0000016",
      "Miglustat",
      "Zavesca, NB-DNJ",
      "Dose-Response Complete.",
      "100",
      "170",
      ">1000",
      ">100",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO",
      "219.28"
    ],
    [
      "ZOX-0000017",
      "NN-DNJ",
      "nan",
      "Dose-Response Complete.",
      "100",
      "4.63",
      "60.1",
      "nan",
      "Plaque Assay",
      "nan",
      "CCCCCCCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO",
      "289.416"
    ],
    [
      "ZOX-0000018",
      "MON-DNJ",
      "UV4, UV4B",
      "Dose-Response Complete.",
      "100",
      "24.5",
      ">500",
      ">10",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "O[C@H]1C[N+](CCCCCCCCCOC)([H])[C@H](CO)[C@@H](O)[C@@H]1O.[Cl-]",
      "319.442"
    ],
    [
      "ZOX-0000019",
      "Daunorubicin",
      "Daunorubicin HCl, Acetyladriamycin, Daunomycin, Leukaemomycin C, Rubidomycin",
      "Initial antiviral complete. Not progressing further.",
      "0.01",
      ">0.01",
      "nan",
      "0.227",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O",
      "563.98"
    ],
    [
      "ZOX-0000020",
      "Silmitasertib",
      "CX-4945",
      "Dose-Response Complete.",
      "10",
      "<0.771",
      ">10",
      "22.8",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "C1=CC(=CC(=C1)Cl)NC2=C3C=CN=CC3=C4C=CC(=CC4=N2)C(=O)O",
      "349.77"
    ],
    [
      "ZOX-0000021",
      "Dabrafenib mesylate",
      "GSK-2118436",
      "Initial antiviral complete. Identified for further screening.",
      "10",
      "nan",
      "nan",
      ">100",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1",
      "615.6681"
    ],
    [
      "ZOX-0000022",
      "Enisamium",
      "FAV00A, Amizon",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">1000",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "[Cl-].C[N+]1=CC=C(C=C1)C(=O)NCC2=CC=CC=C2",
      "354.19"
    ],
    [
      "ZOX-0000023",
      "VR17-04",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "[Cl-].C[N+]1=CC=C(C(OH)=C1)C(=O)NCC2=CC=CC=C2",
      "345.2"
    ],
    [
      "ZOX-0000024",
      "Tamoxifene",
      "Tamoxifen citrate, Nolvadex",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "7.09",
      "Plaque Assay",
      "nan",
      "CC\\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1",
      "563.65"
    ],
    [
      "ZOX-0000025",
      "Raloxifene",
      "Raloxifene Hydrochloride, Estiva",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "91.7",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2",
      "510.04"
    ],
    [
      "ZOX-0000026",
      "Atorvastatin",
      "Lipitor, Atorvastatin calcium",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "35.6",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "O=C(O)C[C@H](O)C[C@H](O)CCn2c(c(c(c2c1ccc(F)cc1)c3ccccc3)C(=O)Nc4ccccc4)C(C)C",
      "558.64"
    ],
    [
      "ZOX-0000027",
      "Tacrolimus",
      "FK-506",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "12.7",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "CO[C@@H]1C[C@@H](CC[C@H]1O)\\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\\C(C)=C\\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC",
      "822.03"
    ],
    [
      "ZOX-0000028",
      "Clomifene",
      "Clomid, Clomifene citrate, Clomiphene",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "5.76",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "ClC(c1ccccc1)=C(c2ccc(OCCN(CC)CC)cc2)c3ccccc3",
      "406"
    ],
    [
      "ZOX-0000029",
      "Ciprofloxacin",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "66.7",
      ">66.7",
      "nan",
      "392",
      "Focus Forming Assay",
      "nan",
      "OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O",
      "331.34"
    ],
    [
      "ZOX-0000030",
      "Linezolid",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "1000",
      ">1000",
      "nan",
      ">1000",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1",
      "337.35"
    ],
    [
      "ZOX-0000031",
      "Lomitapide",
      "Juxtapid, Lojuxta",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "9.26",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "FC(F)(F)c5ccc(cc5)-c1ccccc1C(=O)NC4CCN(CC4)CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c6ccccc26",
      "693.719"
    ],
    [
      "ZOX-0000032",
      "Eliglustat",
      "Genz-112638, Cerdelga, Eliglustat tartrate",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "443",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)C1=CC=C2OCCOC2=C1",
      "959.2"
    ],
    [
      "ZOX-0000033",
      "N,N-dimethylamiloride HCl",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "92.8",
      "Plaque Assay",
      "nan",
      "NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N",
      "294.14"
    ],
    [
      "ZOX-0000034",
      "Dronedarone",
      "MULTAQ, Dronedarone HCl",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "38.1",
      "Plaque Assay",
      "nan",
      "CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2",
      "593.22"
    ],
    [
      "ZOX-0000035",
      "Tigecycline hydrate",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "79.4",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "[H][C@@]12CC3=C(C(O)=C(NC(=O)CNC(C)(C)C)C=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2",
      "585.65"
    ],
    [
      "ZOX-0000036",
      "Rapamycin",
      "Sirolimus, Rapamune",
      "Initial antiviral complete. Not progressing further.",
      "0.001",
      ">0.001",
      "nan",
      ">100",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\\C=C(C)\\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\\C=C\\C=C\\C=C(C)\\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC",
      "914.17"
    ],
    [
      "ZOX-0000037",
      "Nafamostat",
      "Nafamostat mesylate, Fusan",
      "Dose-Response Complete.",
      "10",
      "2.78",
      "4.5",
      "94.1",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC2=C(C=C1)C=C(C=C2)C(N)=N",
      "539.58"
    ],
    [
      "ZOX-0000038",
      "Carmofur",
      "1-hexylcarbamoyl-5-fluorouracil",
      "Initial antiviral complete. Not progressing further.",
      "0.1",
      ">0.1",
      "nan",
      "67.8",
      "Plaque Assay",
      "acid ceramidase inhibitor ",
      "CCCCCCNC(=O)N1C=C(C(=O)NC1=O)F",
      "257.26"
    ],
    [
      "ZOX-0000039",
      "Chloramphenicol",
      "Chloramphenicol hydrate",
      "Initial antiviral complete. Not progressing further.",
      "1000",
      ">1000",
      "nan",
      ">1000",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O",
      "323.13"
    ],
    [
      "ZOX-0000040",
      "Imipramine",
      "Imipramine hydrochloride",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "83",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12",
      "316.87"
    ],
    [
      "ZOX-0000041",
      "Amiodarone",
      "Amiodarone HCl",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "28.6",
      "Focus Forming Assay",
      "nan",
      "CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2",
      "645.32"
    ],
    [
      "ZOX-0000042",
      "Lercanidipine",
      "Lercadip, Lerdip, Zanidip, Lercanidipine HCl",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "13.6",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC",
      "648.19"
    ],
    [
      "ZOX-0000043",
      "Nelfinavir",
      "Nelfinavir mesylate",
      "Initial antiviral complete. Identified for further screening.",
      "10",
      "nan",
      "nan",
      "41",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "[H][C@@]12CCCC[C@]1([H])CN(C[C@@H](O)[C@H](CSC1=CC=CC=C1)NC(=O)C1=C(C)C(O)=CC=C1)[C@@H](C2)C(=O)NC(C)(C)C",
      "663.89"
    ],
    [
      "ZOX-0000044",
      "BIIB021",
      "CNF2024",
      "Initial antiviral complete. Not progressing further.",
      "0.01",
      ">0.01",
      "nan",
      "0.348",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "COC1=C(C)C=NC(=C1C)C[N]2C=NC3=C(Cl)N=C(N)N=C23",
      "318.76"
    ],
    [
      "ZOX-0000045",
      "Teleglenastat",
      "CB-839",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      ">100",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "FC(F)(F)OC1=CC(=CC=C1)CC(=O)NC2=CC=C(CCCCC3=NN=C(NC(=O)CC4=CC=CC=N4",
      "571.57"
    ],
    [
      "ZOX-0000046",
      "4EGI-1",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "19.3",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "OC(=O)C(/CC1=CC=CC=C1[N+]([O-])=O)=N/NC2=NC(=CS2)C3=CC=C(Cl)C(=C3)Cl",
      "451.28"
    ],
    [
      "ZOX-0000047",
      "Roxadustat",
      "FG4592",
      "Dose-Response Complete.",
      "100",
      ">100",
      ">100",
      ">100",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "CC1=NC(C(=O)NCC(O)=O)=C(O)C2=C1C=C(OC1=CC=CC=C1)C=C2",
      "352.34"
    ],
    [
      "ZOX-0000048",
      "SR9009",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      ">100",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "CCOC(=O)N1CCC(C1)CN(CC2=CC=C(C=C2)Cl)CC3=CC=C(S3)[N+](=O)[O-]",
      "437.94026"
    ],
    [
      "ZOX-0000049",
      "Avasimibe",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "9.15",
      "Plaque Assay",
      "nan",
      "CC(C)C1=CC(C(C)C)=C(CC(=O)NS(=O)(=O)OC2=C(C=CC=C2C(C)C)C(C)C)C(=C1)C(C)C",
      "501.73"
    ],
    [
      "ZOX-0000050",
      "PT2385",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "200",
      ">200",
      "nan",
      ">100",
      "Focus Forming Assay",
      "nan",
      "CS(=O)(=O)C1=CC=C(OC2=CC(=CC(F)=C2)C#N)C2=C1[C@H](O)C(F)(F)C2",
      "383.34"
    ],
    [
      "ZOX-0000051",
      "Amiloride hydrochloride",
      "nan",
      "Initial antiviral complete. Identified for further screening.",
      "100",
      ">100",
      "nan",
      "280",
      "Plaque Assay",
      "nan",
      "NC(N)=NC(=O)C1=C(N)N=C(N)C(Cl)=N1",
      "266.09"
    ],
    [
      "ZOX-0000052",
      "HMA",
      "5-(N,N-Hexamethylene)amiloride, Hexamethyleneamiloride",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "8.09",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "C1CCCN(CC1)C2=NC(=C(N=C2Cl)C(=O)N=C(N)N)N",
      "311.77"
    ],
    [
      "ZOX-0000053",
      "2-Deoxyglucose",
      "nan",
      "Initial antiviral complete. Identified for further screening.",
      "100",
      ">100",
      "nan",
      "359",
      "Plaque Assay",
      "Host Cell Targeting Antiviral",
      "OCC1OC(O)CC(O)C1O",
      "164"
    ],
    [
      "ZOX-0000054",
      "Folic acid",
      "Vitamin B9",
      "Initial antiviral complete. Not progressing further.",
      "51.5",
      ">51.5",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "n1c2C(=O)NC(N)=Nc2ncc1CNc3ccc(cc3)C(=O)N[C@H](C(O)=O)CCC(O)=O",
      "441.4"
    ],
    [
      "ZOX-0000055",
      "MED-COV-4280ac29-15",
      "CVD-0002720",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "16.8",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "ClCC(=O)N1CCN(Cc2cccc(Cl)c2)CC1",
      "287.18"
    ],
    [
      "ZOX-0000056",
      "SIM-SYN-f15aaa3a-1",
      "CVD-0003482",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "40.2",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "ClCC(=O)N1CCN(CC1)C(c1ccccc1)c1ccccc1",
      "328.840\u00a0"
    ],
    [
      "ZOX-0000057",
      "MAT-POS-916a2c5a-1",
      "CVD-0002706",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "42.9",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "COc1ccc(cc1OC)C1CC(=NN1C(=O)CCl)c1cccs1",
      "364.84\u00a0"
    ],
    [
      "ZOX-0000058",
      "MAT-POS-916a2c5a-2",
      "CVD-0002707",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      ">100",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "COc1ccccc1OCCNC(=O)c1cc(=O)[nH]c2ccccc12",
      "338.363"
    ],
    [
      "ZOX-0000059",
      "LON-WEI-8f408cad-3",
      "CVD-0001866",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "19.9",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "ClCC(=O)N1CCN(CC1)S(=O)(=O)c1cccs1",
      "308.8"
    ],
    [
      "ZOX-0000060",
      "LON-WEI-adc59df6-47",
      "CVD-0004255",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "38.5",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "CC(C)(C)c1ccc(cc1)N(C(C(=O)NCCc1cccc(F)c1)c1cccnc1)C(=O)C=C",
      "459.565"
    ],
    [
      "ZOX-0000061",
      "MED-COV-4280ac29-31",
      "CVD-0002737",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "7.1",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "ClCC(=O)N1CCN(Cc2cccc3ccccc23)CC1",
      "302.8"
    ],
    [
      "ZOX-0000062",
      "5-Thioguanine",
      "Thioguanine, 154-42-7, Tioguanine, 2-Amino-6-mercaptopurine",
      "In process.",
      "1",
      ">1",
      "nan",
      "nan",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "C1=NC2=C(N1)C(=S)N=C(N2)N",
      "167.19"
    ],
    [
      "ZOX-0000063",
      "Antipain",
      "UNII-47V479BE6L, CCRIS 3605, EINECS 253-631-0",
      "Dose-Response Complete.",
      "100",
      ">100",
      ">100",
      "50.9",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(C)C(C(=O)NC(CCCN=C(N)N)C=O)NC(=O)C(CCCN=C(N)N)NC(=O)NC(CC1=CC=CC=C1)C(=O)O",
      "604.7"
    ],
    [
      "ZOX-0000064",
      "Bismuth (III) Subsalicylate",
      "14882-18-9, Bismuth oxysalicylate, Wismutsubsalicylat, Bismuth oxide salicylate",
      "Initial antiviral complete. Identified for further screening.",
      "10",
      ">10",
      "nan",
      ">100",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "C1=CC=C2C(=C1)C(=O)O[Bi]O2.O",
      "362.09"
    ],
    [
      "ZOX-0000065",
      "N-p-Tosyl-L-phenylalanine chloromethyl ketone",
      "TPCK",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "17.4",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)CCl",
      "351.85"
    ],
    [
      "ZOX-0000066",
      "BAY-11 7082 ",
      "BAY 11-7821,19542-67-7,(E)-3-Tosylacrylonitrile, (E)-3-(p-Toluenesulfonyl)acrylonitrile",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "9.59",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "N#C/C=C/S(=O)(C1=CC=C(C)C=C1)=O",
      "207.25"
    ],
    [
      "ZOX-0000067",
      "Boceprevir",
      "Victrelis, 394730-60-0, SCH 503034, EBP 520",
      "Dose-Response Complete.",
      "100",
      "94.2",
      "106",
      ">100",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "O=C(N3[C@H](C(=O)NC(C(=O)C(=O)N)CC1CCC1)[C@H]2C(C)([C@H]2C3)C)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C",
      "519.7"
    ],
    [
      "ZOX-0000068",
      "Auranofin",
      "2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold, (1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "67.3",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O",
      "678.484"
    ],
    [
      "ZOX-0000069",
      "Cisplatin",
      "cis-Diaminedichloroplatinum, cis-Diamminedichlorplatine, cis-Dichlorodiamine platinum, Platinum, diamminedichloro-NCGC00090759-01",
      "Dose-Response Complete.",
      "100",
      "92.4",
      "113",
      ">100",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "[NH3+]-[Pt-2](Cl)(Cl)[NH3+]",
      "300.01"
    ],
    [
      "ZOX-0000070",
      "N-alpha-Tosyl-L-lysine chloromethyl ketone hydrochloride",
      "TLCK",
      "Initial antiviral complete. Identified for further screening.",
      "100",
      ">100",
      "nan",
      ">100",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "O=S(C1=CC=C(C)C=C1)(N[C@H](C(CCl)=O)CCCCN)=O.Cl",
      "369.3"
    ],
    [
      "ZOX-0000071",
      "IPA 3",
      "Bis(2-hydroxy-1-naphthyl) disulfide, 1,1'-Dithiodi-2-naphthol,UNII-3XFG6MQ9G2",
      "Dose-Response Complete.",
      "100",
      ">100",
      ">100",
      ">100",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "C1=CC=C2C(=C1)C=CC(=C2SSC3=C(C=CC4=CC=CC=C43)O)O",
      "350.45"
    ],
    [
      "ZOX-0000072",
      "8-Hydroxy-5-nitroquinoline",
      "Nitroxoline, 5-nitroquinolin-8-ol, 4008-48-4, 5-Nitro-8-hydroxyquinoline",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "70.3",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "C1=CC2=C(C=CC(=C2N=C1)O)[N+](=O)[O-]",
      "190.16"
    ],
    [
      "ZOX-0000073",
      "NSC95397",
      "93718-83-3, NSC-95397, 2,3-Bis(2-hydroxyethylthio)-1,4-naphthalenedione",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "8.67",
      "Plaque Assay",
      "Direct Acting Antiviral",
      "O=C1C(SCCO)=C(SCCO)C(C2=C1C=CC=C2)=O",
      "310.39"
    ],
    [
      "ZOX-0000074",
      "Toremifene",
      "Toremifene citrate, Fareston",
      "Initial antiviral complete. Not progressing further.",
      "1.67",
      ">1.67",
      "nan",
      "27.3",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O",
      "598.08"
    ],
    [
      "ZOX-0000075",
      "Ruxolitinib",
      "Jafaki ruxolitinib phosphate",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1",
      "306.37"
    ],
    [
      "ZOX-0000076",
      "Celecoxib",
      "Celebrex, Onsenal, Elyxyb",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "76.7",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F",
      "381.37"
    ],
    [
      "ZOX-0000077",
      "Alvelestat",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC1=CC(=CC=C1)N2C(=C(C=C(C2=O)C(=O)NCC3=NC=C(C=C3)S(=O)(=O)C)C4=CC=NN4C)C",
      "545.54"
    ],
    [
      "ZOX-0000078",
      "Rivaroxiban",
      "Xarelto",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "O=C1COCCN1c2ccc(cc2)N3C[C@@H](OC3=O)CNC(=O)c4ccc(s4)Cl",
      "435.882"
    ],
    [
      "ZOX-0000079",
      "Fludarabine",
      "Fludara, 2-fluoro ARA-A",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "15.3",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Fc1nc(c2ncn(c2n1)[C@@H]3O[C@@H]([C@@H](O)[C@@H]3O)CO)N",
      "365.212"
    ],
    [
      "ZOX-0000080",
      "Ambroxol",
      "Mucosolvan, Mucol Brontex",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "45.4",
      "Focus Forming Assay",
      "nan",
      "NC1=C(Br)C=C(Br)C=C1CN[C@H]1CC[C@H](O)CC1",
      "378.1028"
    ],
    [
      "ZOX-0000081",
      "Indinavir",
      "IDV, Crixivan",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](Cc2ccccc2)C(=O)N[C@H]3c4ccccc4C[C@H]3O)O)Cc5cccnc5",
      "613.79"
    ],
    [
      "ZOX-0000082",
      "Itraconazole",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "1.325",
      ">1.325",
      "nan",
      "nan",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1",
      "705.63"
    ],
    [
      "ZOX-0000085",
      "Olaparib",
      "LYNPARZA, AZD-2281, MK-7339",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      ">10",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "COC1CCN(C(C2=C(C=CC(CC3=NNC(C4=CC=CC=C34)=O)=C2)F)=O)CC1",
      "434.47"
    ],
    [
      "ZOX-0000086",
      "PDD00017273",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "5",
      ">5",
      "nan",
      ">10",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "O=C(C1=CC(S(NC2(CC2)C)(=O)=O)=CC=C1N3CC4=CC(C)=NN4C)N(CC5=CN=C(C)S5)C3=O",
      "514.62"
    ],
    [
      "ZOX-0000087",
      "Talazoparib",
      "Talzenna, BMN-673",
      "Initial antiviral complete. Not progressing further.",
      "0.05",
      ">0.05",
      "nan",
      ">10",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "CN1C(=NC=N1)C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F",
      "380.35"
    ],
    [
      "ZOX-0000088",
      "Veliparib",
      "ABT-888",
      "Initial antiviral complete. Not progressing further.",
      "5",
      ">5",
      "nan",
      ">10",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "C[C@]1(C2=NC3=CC=CC(C(N)=O)=C3N2)CCCN1.Cl.Cl",
      "317.21"
    ],
    [
      "ZOX-0000089",
      "NAP-DNJ",
      "nan",
      "Initial antiviral complete. Identified for further screening.",
      "1000",
      "9.92",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "O[C@@H]1[C@@H](CO)N(CCCCCCNC2=C([N+]([O-])=O)C=C(N=[N+]=[N-])C=C2)C[C@H](O)[C@H]1O",
      "nan"
    ],
    [
      "ZOX-0000090",
      "NN-DGJ",
      "nan",
      "Initial antiviral complete. Identified for further screening.",
      "1",
      "158",
      "nan",
      "nan",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "OC[C@H]1N(CCCCCCCCC)C[C@H](O)[C@@H](O)[C@H]1O",
      "nan"
    ],
    [
      "ZOX-0000091",
      "MON-DGJ",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "0.25",
      ">0.25",
      "nan",
      "380",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "C[C@H]1N(CCCCCCCCCOC)C[C@H](O)[C@@H](O)[C@H]1O",
      "nan"
    ],
    [
      "ZOX-0000092",
      "INFa2, Interferon alpha 2",
      "nan",
      "Initial antiviral complete. Identified for further screening.",
      "0.1 \u03bcg/mL",
      "nan",
      "nan",
      "nan",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "nan",
      "nan"
    ],
    [
      "ZOX-0000093",
      "INFL4s70, Interferon lambda 4s70",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "0.1 \u03bcg/mL",
      ">0.1 \u03bcg/mL",
      "nan",
      "nan",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "nan",
      "nan"
    ],
    [
      "ZOX-0000094",
      "INFL4p70, Interferon lambda 4p70",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "0.1 \u03bcg/mL",
      ">0.1 \u03bcg/mL",
      "nan",
      "nan",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "nan",
      "nan"
    ],
    [
      "ZOX-0000095",
      "INFL4, Interferon lambda 4",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "0.1 \u03bcg/mL",
      ">0.1 \u03bcg/mL",
      "nan",
      "nan",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "nan",
      "nan"
    ],
    [
      "ZOX-0000096",
      "INFL3, Interferon lambda 3 (Prep 1H)",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "0.1 \u03bcg/mL",
      ">0.1 \u03bcg/mL",
      "nan",
      "nan",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "nan",
      "nan"
    ],
    [
      "ZOX-0000097",
      "INFL3, Interferon lambda 3 (Prep 1)",
      "nan",
      "Initial antiviral complete. Identified for further screening.",
      "0.1 \u03bcg/mL",
      "nan",
      "nan",
      "nan",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "nan",
      "nan"
    ],
    [
      "ZOX-0000098",
      "LON-WEI-ff7b210a-4",
      "CVD-0007438",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "89",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CS(=O)(=O)C1=NC=C(Cl)C(=N1)C(=O)NC1=CC=CC=C1CC1=CC=CC=C1 ",
      "401"
    ],
    [
      "ZOX-0000099",
      "LOR-NEU-c8f11034-5",
      "CVD-0005886",
      "Initial antiviral complete. Identified for further screening.",
      "100",
      "15.2",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "BrC1=CC=C(CN2C(=O)C(=O)C3=CC=CC=C23)C=C1",
      "318"
    ],
    [
      "ZOX-0000100",
      "LON-WEI-babf2c61-1",
      "CVD-0006798",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(C)(C)C1=CC=C(C=C1)N(C(C(=O)NCCC1=CC=CC(F)=C1)C1=CN=CC(Cl)=C1)C(=O)C=C",
      "494"
    ],
    [
      "ZOX-0000101",
      "LOR-NEU-c8f11034-2",
      "CVD-0005883",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "BrC1=CC=C(CN2C(=O)C(=O)C3=CC=CC(Br)=C23)C=C1",
      "395"
    ],
    [
      "ZOX-0000102",
      "TRY-UNI-2eddb1ff-7",
      "CVD-0004754",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC1=CC=NC=C1NC(=O)CC1=CC(Cl)=CC(OC2CC(=O)N2)=C1 ",
      "345"
    ],
    [
      "ZOX-0000103",
      "ALP-POS-c59291d4-5",
      "CVD-0006354",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "ClC1=CN=CC(OC(=O)C2=C3C=CNC3=CC=C2)=C1",
      "272"
    ],
    [
      "ZOX-0000104",
      "ALP-POS-c59291d4-6",
      "CVD-0006355",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(C)(C)NC(=O)C(N(C(=O)C1=CC=CO1)C1=CC=C(C=C1)C(C)(C)C)C1=CC=CN=C1 ",
      "433"
    ],
    [
      "ZOX-0000105",
      "ALP-POS-d2866bdf-1",
      "CVD-0007225",
      "Initial antiviral complete. Identified for further screening.",
      "100",
      "15.3",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CN(C)C1=CC=C(C=C1)N(CC1=CSC=C1)C(=O)CN1N=NC2=CC=CC=C12 ",
      "391"
    ],
    [
      "ZOX-0000106",
      "JOR-UNI-2fc98d0b-12",
      "CVD-0001724",
      "Initial antiviral complete. Identified for further screening.",
      "100",
      "14.9",
      "nan",
      "21.4",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "ClC1=CC=CC(=C1)N(CCC1CCCCC1)C(=O)NC1=CC=CN=C1",
      "357"
    ],
    [
      "ZOX-0000107",
      "Sinefungin",
      "Adenosyl-ornithine",
      "Initial antiviral complete. Not progressing further.",
      "500",
      ">500",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)C[C@H](CC[C@@H](C(=O)O)N)N)O)O)N",
      "381.39"
    ],
    [
      "ZOX-0000108",
      "TSF_217",
      "Lactivicin derivative,352",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "nan",
      "nan",
      "nan"
    ],
    [
      "ZOX-0000109",
      "PLTV",
      "Lactivicin",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "nan",
      "nan",
      "nan"
    ],
    [
      "ZOX-0000110",
      "BI41",
      "Penicllin sulfone derivate 1",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "nan",
      "nan",
      "nan"
    ],
    [
      "ZOX-0000111",
      "BI50",
      "Penicllin sulfone derivate 2",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "nan",
      "nan",
      "nan"
    ],
    [
      "ZOX-0000112",
      "BI71-2",
      "Penicllin sulfone derivate 3",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "nan",
      "nan",
      "nan"
    ],
    [
      "ZOX-0000113",
      "BI63",
      "Penicllin sulfone derivate 4",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "nan",
      "nan",
      "nan"
    ],
    [
      "ZOX-0000114",
      "Tenegliptin",
      "Tenelia, Teneligliptin",
      "Initial antiviral complete. Not progressing further.",
      "47.7",
      ">47.7",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC1=NN(C(=C1)N2CCN(CC2)[C@H]3C[C@H](NC3)C(=O)N4CCSC4)C5=CC=CC=C5",
      "426.58"
    ],
    [
      "ZOX-0000115",
      "Ponatinib",
      "Iclusig, AP24534",
      "Initial antiviral complete. Identified for further screening.",
      "10",
      ">10",
      "nan",
      "67.7",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1",
      "532.56"
    ],
    [
      "ZOX-0000116",
      "LOR-NOR-30067bb9-7",
      "CVD-0009876",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COC1=CC=C(CN2C(=O)C(=O)C3=CC(Br)=CC(C)=C23)C=C1OC ",
      "390.233"
    ],
    [
      "ZOX-0000117",
      "DAN-LON-a5fc619e-8",
      "CVD-0000654",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "77.7",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "ClCC(=O)N1CC2CC1CN2CC1=CC=CC(Cl)=C1",
      "299.2"
    ],
    [
      "ZOX-0000118",
      "DAN-LON-a5fc619e-3",
      "CVD-0000649",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "79.2",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(C)C[C@@H]1CN(CCN1CC1=CC=CC(Cl)=C1)C(=O)CCl",
      "343.29"
    ],
    [
      "ZOX-0000119",
      "LON-WEI-babf2c61-9",
      "CVD-0006806",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "77.3",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "FC1=CC=CC(CCNC(=O)C(N(C(=O)C=C)C2=CC=C(C=C2)C(F)",
      "471.456"
    ],
    [
      "ZOX-0000120",
      "MED-COV-4280ac29-30",
      "CVD-0002736",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "87.1",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COC1=CC=C(C=C1OC)C1CC(=NN1C(=O)CCl)C1=CC=CC=C1 ",
      "358.82"
    ],
    [
      "ZOX-0000121",
      "JAN-GHE-5a013bed-2",
      "CVD-0004611",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "104",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "ClC1=CC=CC(CC(=O)NN2C=NC3=CC=CC=C23)=C1",
      "285.73"
    ],
    [
      "ZOX-0000122",
      "EDJ-MED-6af13d92-3",
      "CVD-0005777",
      "Initial antiviral complete. Identified for further screening.",
      "100",
      "15.3",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COC1=CC=CC=C1OCCNC(=O)C1=CC(=O)NC2=CC=CC(OC)=C12 ",
      "368.389"
    ],
    [
      "ZOX-0000123",
      "ADA-UCB-6c2cb422-1",
      "CVD-0007756",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "ClC1=CC=CC(CC(=O)NC2=CN=CC3=CC=CC=C23)=C1",
      "296.75"
    ],
    [
      "ZOX-0000124",
      "EDJ-MED-6af13d92-1",
      "CVD-0005775",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COC1=CC=CC=C1OCCNC(=O)C1=CC(=O)NC2=CC=CC(C)=C12 ",
      "352.39"
    ],
    [
      "ZOX-0000125",
      "JAG-UCB-a3ef7265-20",
      "CVD-0005329",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "ClC1=CC=C2OCCC(C(=O)NC3=NN=CN3C3CC3)C2=C1",
      "318.76"
    ],
    [
      "ZOX-0000126",
      "TAT-ENA-80bfd3e5-1; MAT-POS-e10a589d-2",
      "CVD-0008035",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CN(C)S(=O)(=O)C1=CC=CC(=C1)C(=O)NC1=C(N=C2SC=CN12)C1=CC=CC=C1 ",
      "426.51"
    ],
    [
      "ZOX-0000127",
      "MAT-POS-e10a589d-1",
      "CVD-0012923",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "8.97",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "OCCN1C(CSC2=NC3=CC=CC=C3O2)=NC2=CC=C(Cl)C=C12",
      "359.83"
    ],
    [
      "ZOX-0000128",
      "PAU-UNI-8cdd41c7-1",
      "CVD-0003037",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "32.2",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "ClCC(=O)N1CCN(CC2=CC(Cl)=CC(Cl)=C2)CC1",
      "321.63"
    ],
    [
      "ZOX-0000129",
      "LON-WEI-2e27a2e5-1",
      "CVD-0010542",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "81.7",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(C)(C)C1=CC=C(C=C1)N(C(C(=O)NCCC1=CC=CC(F)=C1)C1=CC=CN=C1)C(=O)C",
      "499.586"
    ],
    [
      "ZOX-0000130",
      "TRY-UNI-714a760b-3",
      "CVD-0003629",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC1=C(N)C=NC=C1NC(=O)CC1=CC=CC(Cl)=C1",
      "275.74"
    ],
    [
      "ZOX-0000131",
      "AGN-NEW-891393a6-1",
      "CVD-0000033",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COC1=CC(Cl)=CC(OC(=O)NC2=CC=CN=C2)=C1",
      "278.69"
    ],
    [
      "ZOX-0000132",
      "ALP-POS-c59291d4-2",
      "CVD-0006351",
      "Initial antiviral complete. Identified for further screening.",
      "100",
      "31.5",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CCC(=O)NC1=CC=C(C=C1)N(CC1=CSC=C1)C(=O)CN1N=NC2=CC=CC=C12 ",
      "419.5"
    ],
    [
      "ZOX-0000133",
      "ALP-POS-91609ae9-3",
      "CVD-0006189",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "86.1",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "ClC1=CC=CC(CN2CCN(C2=O)C2=C3C=NNC3=CC=N2)=C1 ",
      "327.77"
    ],
    [
      "ZOX-0000134",
      "DAV-CRI-14a23e73-1",
      "CVD-0000864",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "81.8",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(NC(=O)CCl)C1=CC(Cl)=CC(=C1)C1=CC=C(C=C1)S(N)(=O)=O ",
      "387.28"
    ],
    [
      "ZOX-0000135",
      "BEN-DND-93268d01-8",
      "CVD-0005075",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(=O)N1CCN(CC(=O)NC2=CN=CC=C2C)CC1",
      "276.34"
    ],
    [
      "ZOX-0000136",
      "BOLD100",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "nan",
      "500"
    ],
    [
      "ZOX-0000137",
      "Alendronate",
      "Fosamax, Alendronic Acid, Alendronate Sodium, Binosto",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.[Na+]",
      "271.08"
    ],
    [
      "ZOX-0000138",
      "Clodronate",
      "Clodronic Acid, Sodium Clodronate",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl",
      "244.89"
    ],
    [
      "ZOX-0000139",
      "Zolendronate",
      "Zoledronic Acid, Zometa, Reclast",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "29.2",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O",
      "272.09"
    ],
    [
      "ZOX-0000140",
      "Ox14",
      "1-fluoro-2-(imidazo-[1,2 alpha]pyridin-3-yl)-ethyl-bisphosphonate",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "16",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "C9H11FN2O6P2.0.5H2O",
      "333.15"
    ],
    [
      "ZOX-0000141",
      "Azetronam",
      "IAL-MD0005",
      "Initial antiviral complete. Not progressing further.",
      "50",
      ">50",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N",
      "435.43"
    ],
    [
      "ZOX-0000142",
      "IAL-MD0128",
      "24218528",
      "In process.",
      "50",
      ">50",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "O=C(C1=CN=C(C2=C3C(N(C)C=C3)=NC=C2)C=C1)N4CCCCC4",
      "320.4"
    ],
    [
      "ZOX-0000143",
      "IAL-MD0131",
      "40017795",
      "Initial antiviral complete. Not progressing further.",
      "50",
      ">50",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "O=C(C1=CC=C(C2=C3C(N(C)C=C3)=NC=C2)O1)N4CCOCC4",
      "311.3"
    ],
    [
      "ZOX-0000144",
      "Quercetin",
      "Sophoretin; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one ",
      "In process.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "nan",
      "302.23"
    ],
    [
      "ZOX-0000145",
      "ALP-POS-3b848b35-2",
      "CVD-0010545",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "ClC1=CC(CC(=O)NC2=CN=CC3=CC=CC=C23)=CC(OC2CC(=O)N2)=C1 ",
      "381.82"
    ],
    [
      "ZOX-0000146",
      "VLA-UCB-1dbca3b4-15",
      "CVD-0012801",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "ClC1=CC=C2OCCC(C(=O)NC3=CN=CC4=CC=CC=C34)C2=C1 ",
      "338.79"
    ],
    [
      "ZOX-0000147",
      "Activin A",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "33",
      ">33",
      "nan",
      "nan",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "nan",
      "407.94"
    ],
    [
      "ZOX-0000148",
      "EDJ-MED-c314995a-1",
      "CVD-0011943",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "12.9",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cccc(c1)N(CCC1CCCCC1)C(=O)Nc1cncc2ccccc12",
      "407.94"
    ],
    [
      "ZOX-0000149",
      "MAT-POS-11b63608-1",
      "CVD-0013197",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "26",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Brc1ccc2OCCC(C(=O)Nc3cncc4ccccc34)c2c1",
      "383.245"
    ],
    [
      "ZOX-0000150",
      "MAT-POS-9ff17035-3",
      "CVD-0012742",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "2.08",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cc(CC(=O)Nc2cncc3ccccc23)cc(Oc2cccnc2)c1",
      "389.84"
    ],
    [
      "ZOX-0000151",
      "MAT-POS-bbbbc21a-3",
      "CVD-0013195",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cc2CCOc2c(CC(=O)Nc2cncc3ccccc23)c1",
      "338.79"
    ],
    [
      "ZOX-0000152",
      "MAT-POS-f2460aef-3",
      "CVD-0013166",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "79.3",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(C)(C)c1ccc(cc1)N(C(C(=O)NCCc1cccc(F)c1)c1cccnc1)C(=O)c1c[nH]cn1",
      "499.59"
    ],
    [
      "ZOX-0000153",
      "MAT-POS-f2460aef-4",
      "CVD-0013167",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "9.79",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(C)(C)c1ccc(cc1)N(C(C(=O)NCCc1cccc(F)c1)c1cccnc1)C(=O)c1ccc(Cl)o1",
      "534.03"
    ],
    [
      "ZOX-0000154",
      "MAT-POS-f7918075-2",
      "CVD-0012962",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2OCC(C(=O)Nc3cncc4ccccc34)c2c1",
      "324.76"
    ],
    [
      "ZOX-0000155",
      "MAT-POS-fa06b69f-6",
      "CVD-0013057",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "O=C1OC(=N\\C1=C/c1ccc(s1)N1CCOCC1)c1cccs1",
      "346.42"
    ],
    [
      "ZOX-0000156",
      "PET-UNK-1901c25b-1",
      "CVD-0013216",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "24.5",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CN(C)c1ccc(cc1)N(Cc1ccsc1)C(=O)Cc1cncc2ccccc12",
      "401.53"
    ],
    [
      "ZOX-0000157",
      "EDJ-MED-00c1612e-1",
      "CVD-0010618",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "4.9",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COc1ccc2cncc(NC(=O)Cc3cccc(Cl)c3)c2c1",
      "326.78"
    ],
    [
      "ZOX-0000158",
      "MAT-POS-b3e365b9-1",
      "CVD-0013192",
      "Dose-Response Complete.",
      "nan",
      "1.99",
      ">10",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2OCC[C@@H](C(=O)Nc3cncc4ccccc34)c2c1",
      "338.79"
    ],
    [
      "ZOX-0000159",
      "MAT-POS-f2460aef-1",
      "CVD-0013164",
      "Dose-Response Complete.",
      "nan",
      "2.89",
      ">10",
      "14.5",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(C)(C)c1ccc(cc1)N([C@H](C(=O)NCCc1cccc(F)c1)c1cccnc1)C(=O)c1ccco1",
      "499.586"
    ],
    [
      "ZOX-0000160",
      "ALP-POS-c59291d4-1",
      "CVD-0006350",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "O=C(Cn1nnc2ccccc12)N(Cc1ccsc1)c1ccc(cc1)-c1ccccc1",
      "424.52"
    ],
    [
      "ZOX-0000161",
      "MAT-POS-3b92565d-1",
      "CVD-0011616",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "13.7",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COc1ccc(Cl)cc1CC(=O)Nc1cncc2ccccc12",
      "326.78"
    ],
    [
      "ZOX-0000162",
      "ERI-UCB-ce40166b-17",
      "CVD-0007597",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cc(OCCNC(=O)c2cc(=O)[nH]c3ccccc23)cc(OC2CC(=O)N2)c1",
      "427.84"
    ],
    [
      "ZOX-0000163",
      "Clofazimine",
      "Lamprene",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "39.8",
      "Focus Forming Assay",
      "nan",
      "CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl",
      "473.4"
    ],
    [
      "ZOX-0000164",
      "Niclosamide",
      "5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "3.05",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O",
      "327.12"
    ],
    [
      "ZOX-0000165",
      "Favipiravir",
      "6-fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "C1=C(N=C(C(=O)N1)C(=O)N)F",
      "157.1"
    ],
    [
      "ZOX-0000166",
      "Merimepodib",
      "nan",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "1.02",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)OC3CCOC3)C4=CN=CO4",
      "452.5"
    ],
    [
      "ZOX-0000167",
      "Nitazoxanide",
      "Alinia",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "1.57",
      "Focus Forming Assay",
      "Host Cell Targeting Antiviral",
      "CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]",
      "307.28"
    ],
    [
      "ZOX-0000168",
      "Daclatasvir",
      "Daklinza",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "34",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC",
      "738.9"
    ],
    [
      "ZOX-0000169",
      "Camostate",
      "Camostat",
      "Initial antiviral complete. Not progressing further.",
      "> 100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N",
      "398.4"
    ],
    [
      "ZOX-0000170",
      "MAT-POS-8a69d52e-2",
      "CVD-0013291",
      "Dose-Response Complete.",
      "nan",
      "1.82",
      "2.93",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "C[C@@H]1C[C@H](C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2O1",
      "352.82"
    ],
    [
      "ZOX-0000171",
      "EDJ-MED-e4b030d8-2",
      "CVD-0013199",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "C[C@@H]1C[C@@H](C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2O1",
      "352.82"
    ],
    [
      "ZOX-0000172",
      "JOH-MSK-46727e7b-1",
      "CVD-0013146",
      "Dose-Response Complete.",
      "nan",
      "3.67",
      "9.79",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC1CCNC1=O)C(O)S(O)(=O)=O",
      "485.55"
    ],
    [
      "ZOX-0000173",
      "LON-WEI-5e7d1b3e-72",
      "CVD-0010838",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "O=c1oc(Nc2ccccc2)nc2ccccc12",
      "238.246"
    ],
    [
      "ZOX-0000174",
      "LON-WEI-5e7d1b3e-68",
      "CVD-0010835",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COc1cccc(c1)C(=O)Nc1n[nH]c(SCc2ccc(Cl)cc2)n1",
      "374.84"
    ],
    [
      "ZOX-0000175",
      "ALP-POS-6d04362c-2",
      "CVD-0012949",
      "Dose-Response Complete.",
      "nan",
      "3.76",
      "6.54",
      "79",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CN(C)c1ccc(cc1)N(Cc1cccc(Cl)c1)C(=O)Cn1nnc2ccccc12",
      "419.91"
    ],
    [
      "ZOX-0000176",
      "MAT-POS-54c4bf04-3",
      "CVD-0014251",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "72.2",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cccc(c1)N1CCN(CC1)C(=O)c1cncc2ccccc12",
      "351.83"
    ],
    [
      "ZOX-0000177",
      "JOH-UNI-ea1df7a8-1",
      "CVD-0014244",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "27.6",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2OCCN(C(=O)Cc3cncc4ccccc34)c2c1",
      "338.79"
    ],
    [
      "ZOX-0000178",
      "MAT-POS-8d5af1ef-1",
      "CVD-0014153",
      "Dose-Response Complete.",
      "nan",
      "23",
      "87.9",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Brc1ccc2NC(=O)CC(C(=O)Nc3cncc4ccccc34)c2c1",
      "396.244"
    ],
    [
      "ZOX-0000179",
      "MAT-POS-3b536971-1",
      "CVD-0014247",
      "Dose-Response Complete.",
      "nan",
      "7.9",
      "115",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COc1ccc(Cl)cc1OCCNC(=O)c1cc(=O)[nH]c2cccc(OC)c12",
      "402.83"
    ],
    [
      "ZOX-0000180",
      "ALP-POS-696356e4-1",
      "CVD-0014383",
      "Dose-Response Complete.",
      "nan",
      "3.23",
      "3.52",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Fc1ccc2cncc(NC(=O)C3CCOc4ccc(Cl)cc34)c2c1",
      "356.78"
    ],
    [
      "ZOX-0000181",
      "MAT-POS-53907a1c-3",
      "CVD-0013693",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "81.1",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cc(OC2CC(=O)N2)cc(c1)N(CCC1CCCCC1)C(=O)Nc1cncc2ccccc12",
      "493"
    ],
    [
      "ZOX-0000182",
      "MAT-POS-23a8a11a-1",
      "CVD-0014468",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc(CC(=O)Nc2cncc3ccccc23)cc1Cl",
      "331.2"
    ],
    [
      "ZOX-0000183",
      "PET-UNK-c9c1e0d8-3",
      "CVD-0011629",
      "Dose-Response Complete.",
      "nan",
      "8.97",
      "10.4",
      "77",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cccc(c1)C1CCCN(C1=O)c1cncc2ccccc12",
      "336.82"
    ],
    [
      "ZOX-0000184",
      "VLA-UCB-29506327-1",
      "CVD-0014471",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "70.4",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2OCCC3(NC(=O)N(C3=O)c3cncc4ccccc34)c2c1",
      "379.8"
    ],
    [
      "ZOX-0000185",
      "MAT-POS-0c8fa4a7-1",
      "CVD-0013694",
      "Dose-Response Complete.",
      "nan",
      "9.08",
      "11",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2CCC=C(C(=O)Nc3cncc4ccccc34)c2c1",
      "334.8"
    ],
    [
      "ZOX-0000186",
      "ALP-POS-477dc5b7-1",
      "CVD-0013211",
      "Dose-Response Complete.",
      "nan",
      "6.88",
      "11.5",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2CCCC(C(=O)Nc3cncc4ccccc34)c2c1",
      "336.82"
    ],
    [
      "ZOX-0000187",
      "ALP-POS-477dc5b7-2",
      "CVD-0013212",
      "Dose-Response Complete.",
      "nan",
      "2.19",
      "3.76",
      "68.7",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2NCCC(C(=O)Nc3cncc4ccccc34)c2c1",
      "337.81"
    ],
    [
      "ZOX-0000188",
      "MAT-POS-8a69d52e-6",
      "CVD-0013295",
      "Dose-Response Complete.",
      "nan",
      "0.915",
      "1.01",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "C[C@H]1COC2=C(C=C(Cl)C=C2)[C@@H]1C(=O)NC1=C2C=CC=CC2=CN=C1",
      "352.82"
    ],
    [
      "ZOX-0000189",
      "EDJ-MED-e4b030d8-13",
      "CVD-0013210",
      "Dose-Response Complete.",
      "nan",
      "1.67",
      "3.02",
      "74.1",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "C[C@]1(CCOc2ccc(Cl)cc12)C(=O)Nc1cncc2ccccc12",
      "352.82"
    ],
    [
      "ZOX-0000190",
      "PET-UNK-c9c1e0d8-4",
      "CVD-0011630",
      "Dose-Response Complete.",
      "nan",
      "3.57",
      "4.16",
      "74.4",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cccc(c1)C1CCN(C1=O)c1cncc2ccccc12",
      "322.79"
    ],
    [
      "ZOX-0000191",
      "RBN-2397",
      "Atamparib",
      "Initial antiviral complete. Not progressing further.",
      "3.3",
      ">3.3",
      "nan",
      "86.7",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(COCCC(=O)N1CCN(CC1)C2=NC=C(C=N2)C(F)(F)F)NC3=C(C(=O)NN=C3)C(F)(F)F",
      "523.4"
    ],
    [
      "ZOX-0000192",
      "RBN012759",
      "7-(cyclopropylmethoxy)-5-fluoro-2-{[(trans-4-hydroxycyclohexyl)sulfanyl]methyl}quinazolin-4(3H)-one",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "C1CC1COC2=CC3=C(C(=C2)F)C(=O)NC(=N3)CSC4CCC(CC4)O",
      "378.5"
    ],
    [
      "ZOX-0000193",
      "ALP-POS-966f8da6-2",
      "CVD-0014245",
      "Initial antiviral complete. Not progressing further.",
      "33.3",
      ">33.3",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(=O)N1CCC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc12",
      "379.84"
    ],
    [
      "ZOX-0000194",
      "MAT-POS-090737b9-1",
      "CVD-0015227",
      "Dose-Response Complete.",
      "nan",
      "2.8",
      "3.57",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2OCCC(C(=O)N(C(=O)C=C)c3cncc4ccccc34)c2c1",
      "392.84"
    ],
    [
      "ZOX-0000195",
      "rel-EDJ-MED-12c115cc-1",
      "CVD-0014914",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "14.6",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2OC[C@@H](C(=O)Nc3cncc4ccccc34)c2c1",
      "324.76"
    ],
    [
      "ZOX-0000196",
      "RAL-THA-4aa06b95-1",
      "CVD-0014255",
      "Dose-Response Complete.",
      "nan",
      "35.1",
      ">100",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "NC(=O)N1CCC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc12",
      "380.83"
    ],
    [
      "ZOX-0000197",
      "MAT-POS-6c284e65-1",
      "CVD-0015011",
      "Dose-Response Complete.",
      "nan",
      "3.01",
      "3.52",
      "57.8",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CN(C)c1ccc(nc1)N(Cc1cccc(Cl)c1)C(=O)Cc1cncc2ccccc12",
      "430.94"
    ],
    [
      "ZOX-0000198",
      "rac-PET-UNK-29afea89-2",
      "CVD-0015328",
      "Dose-Response Complete.",
      "nan",
      "1.01",
      "1.19",
      "104",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COC1(CCOc2ccc(Cl)cc12)C(=O)Nc1cncc2ccccc12",
      "368.82"
    ],
    [
      "ZOX-0000199",
      "BRU-THA-92256091-17",
      "CVD-0014292",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(C)Oc1ccc(cc1)N(C(C(=O)NCCc1cccc(F)c1)c1cccnc1)C(=O)c1c[nH]cn1",
      "501.562"
    ],
    [
      "ZOX-0000200",
      "MIC-UNK-91acba05-6",
      "CVD-0013559",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "37",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CN1CCC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc12",
      "351.83"
    ],
    [
      "ZOX-0000201",
      "ALP-POS-ce760d3f-1",
      "CVD-0014502",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Oc1cc(Cl)cc2C(CCOc12)C(=O)Nc1cncc2ccccc12",
      "354.79"
    ],
    [
      "ZOX-0000202",
      "RAL-THA-2d450e86-17",
      "CVD-0015041",
      "Dose-Response Complete.",
      "nan",
      "2.89",
      "4.02",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cc(CC(=O)Nc2cncc3ccccc23)cc(c1)C#N",
      "321.76"
    ],
    [
      "ZOX-0000203",
      "RAL-THA-2d450e86-16",
      "CVD-0015040",
      "Dose-Response Complete.",
      "nan",
      "3.32",
      "3.86",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Fc1cc(F)cc(CC(=O)Nc2cncc3ccccc23)c1",
      "298.293"
    ],
    [
      "ZOX-0000204",
      "RAL-THA-2d450e86-14",
      "CVD-0015038",
      "Dose-Response Complete.",
      "nan",
      "3.03",
      "3.75",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Fc1cc(Cl)cc(CC(=O)Nc2cncc3ccccc23)c1",
      "314.74"
    ],
    [
      "ZOX-0000205",
      "ALP-POS-869ac754-1",
      "CVD-0015012",
      "Dose-Response Complete.",
      "nan",
      "1.01",
      "1.37",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cc2OCCC(C(=O)Nc3cncc4ccccc34)c2cc1Cl",
      "373.23"
    ],
    [
      "ZOX-0000206",
      "BEN-DND-c852c98b-5",
      "CVD-0014233",
      "Dose-Response Complete.",
      "nan",
      "9.27",
      "11.8",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CS(=O)(=O)c1ccc2cncc(NC(=O)C3CCOc4ccc(Cl)cc34)c2c1",
      "416.88"
    ],
    [
      "ZOX-0000207",
      "RAL-THA-8416115c-6",
      "CVD-0014266",
      "Dose-Response Complete.",
      "nan",
      "5.91",
      "7.73",
      "41.4",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2N(Cc3ccn[nH]3)CCC(C(=O)Nc3cncc4ccccc34)c2c1",
      "417.9"
    ],
    [
      "ZOX-0000208",
      "RAL-THA-2d450e86-6",
      "CVD-0015030",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Fc1ccc(CC(=O)Nc2cncc3ccccc23)cc1Cl",
      "314.74"
    ],
    [
      "ZOX-0000209",
      "ALP-UNI-3735e77e-2",
      "CVD-0015022",
      "Dose-Response Complete.",
      "nan",
      "3.19",
      "3.53",
      "> 87.1",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cc(Cl)c2OCCC(C(=O)Nc3cncc4ccccc34)c2c1",
      "373.23"
    ],
    [
      "ZOX-0000210",
      "ALP-POS-d91e0300-1",
      "CVD-0015066",
      "Dose-Response Complete.",
      "nan",
      "1.01",
      "1.21",
      "74.4",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Fc1cc2OCCC(C(=O)Nc3cncc4ccccc34)c2cc1Cl",
      "356.78"
    ],
    [
      "ZOX-0000211",
      "rel-PET-UNK-29afea89-2",
      "CVD-0013943",
      "Dose-Response Complete.",
      "nan",
      "0.241",
      "0.52",
      "59.9",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CO[C@]1(CCOc2ccc(Cl)cc12)C(=O)Nc1cncc2ccccc12",
      "368.82"
    ],
    [
      "ZOX-0000212",
      "rel-EDJ-MED-92e193ae-1",
      "CVD-0014805",
      "Dose-Response Complete.",
      "nan",
      "0.995",
      "1.14",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2NCC[C@@H](C(=O)Nc3cncc4ccccc34)c2c1",
      "337.81"
    ],
    [
      "ZOX-0000213",
      "T-5224",
      "3-(5-(4-(cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxybenzo[d]isoxazol-6-yl)methoxy)phenyl)propanoic acid",
      "Initial antiviral complete. Not progressing further.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "nan",
      "C1CCC(C1)OC2=CC(=C(C=C2)C(=O)C3=CC(=C(C=C3)OCC4=CC5=C(C=C4)C(=O)NO5)CCC(=O)O)O",
      "517.5"
    ],
    [
      "ZOX-0000214",
      "ALP-POS-c3a96089-4",
      "CVD-0014210",
      "Dose-Response Complete.",
      "nan",
      "5.52",
      ">10",
      "22.8",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(=O)Nc1ccc(cn1)N(Cc1cccc(Cl)c1)C(=O)Cc1cncc2ccccc12",
      "444.92"
    ],
    [
      "ZOX-0000215",
      "VLA-UCB-50c39ae8-7",
      "CVD-0013309",
      "Dose-Response Complete.",
      "nan",
      "8.47",
      "9.55",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2OCC[C@@H](C(=O)N(C(=O)C=C)c3cncc4ccccc34)c2c1",
      "392.84"
    ],
    [
      "ZOX-0000216",
      "ALP-UNI-3735e77e-4",
      "CVD-0015024",
      "Dose-Response Complete.",
      "nan",
      "0.856",
      "4.3",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cc2NCCC(C(=O)Nc3cncc4ccccc34)c2cc1Cl",
      "372.25"
    ],
    [
      "ZOX-0000217",
      "BEN-BAS-c2bc0d80-6",
      "CVD-0014160",
      "Dose-Response Complete.",
      "nan",
      "1.04",
      "1.12",
      "49.2",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2OCCC3(CC(=O)N(C3=O)c3cncc4ccccc34)c2c1",
      "378.81"
    ],
    [
      "ZOX-0000218",
      "MAT-POS-3b97339c-2",
      "CVD-0016321",
      "Dose-Response Complete.",
      "nan",
      "0.843",
      "4.77",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "N[C@@]1(CCOc2ccc(Cl)cc12)C(=O)Nc1cncc2ccccc12",
      "353.81"
    ],
    [
      "ZOX-0000219",
      "MAT-POS-e69ad64a-2",
      "CVD-0015332",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2OCC(C(=O)N(C(=O)C=C)c3cncc4ccccc34)c2c1",
      "378.81"
    ],
    [
      "ZOX-0000220",
      "EDJ-MED-d08626de-3",
      "CVD-0015340",
      "Initial antiviral complete. Not progressing further.",
      "0.1",
      ">0.1",
      "nan",
      "13.4",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CO[C@@]1(CCOc2cc(Cl)c(Cl)cc12)C(=O)Nc1cncc2ccccc12",
      "403.26"
    ],
    [
      "ZOX-0000221",
      "EDJ-MED-37aac4bd-4",
      "CVD-0015861",
      "Initial antiviral complete. Not progressing further.",
      "0.1",
      ">0.1",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COC1(CCOc2c(F)cc(F)cc12)C(=O)Nc1cncc2ccccc12",
      "370.356"
    ],
    [
      "ZOX-0000222",
      "MAT-POS-a13804f0-3",
      "CVD-0016447",
      "Dose-Response Complete.",
      "nan",
      "1.04",
      "1.12",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Fc1cc2OCC[C@@H](C(=O)Nc3cncc4ccccc34)c2cc1Cl",
      "356.78"
    ],
    [
      "ZOX-0000223",
      "MAT-POS-f9802937-8",
      "CVD-0015381",
      "Dose-Response Complete.",
      "nan",
      "0.843",
      "4.77",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cc2NCC[C@@H](C(=O)Nc3cncc4ccccc34)c2cc1Cl",
      "372.25"
    ],
    [
      "ZOX-0000224",
      "MAT-POS-a13804f0-4",
      "CVD-0016448",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cccc(c1)C(NC(=O)[C@@H]1CC[C@@H](O1)C(=O)N1CCCC1)C(=O)Nc1cncc2ccccc12",
      "506.99"
    ],
    [
      "ZOX-0000225",
      "ALP-POS-fe871b40-11",
      "CVD-0015853",
      "Dose-Response Complete.",
      "nan",
      "1.11",
      "1.43",
      "24.5",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COC1(CCOc2cc(F)c(Cl)cc12)C(=O)Nc1cncc2ccccc12",
      "386.81"
    ],
    [
      "ZOX-0000226",
      "MAT-POS-78e1d523-1",
      "CVD-0016254",
      "Dose-Response Complete.",
      "nan",
      "2.2",
      "4.26",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2SCCC(C(=O)Nc3cncc4ccccc34)c2c1",
      "354.85"
    ],
    [
      "ZOX-0000227",
      "MAT-POS-932d1078-3",
      "CVD-0016505",
      "Dose-Response Complete.",
      "nan",
      "0.152",
      ">1",
      "37.2",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CO[C@]1(CCOc2c(F)cc(F)cc12)C(=O)Nc1cncc2ccccc12",
      "370.356"
    ],
    [
      "ZOX-0000228",
      "Remdesivir",
      "CVD-0016508",
      "Dose-Response Complete.",
      "nan",
      "0.549",
      "1.01",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CCC(CC)COC(=O)[C@H](C)NP(=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)c1ccc2c(N)ncnn12)Oc1ccccc1",
      "602.585"
    ],
    [
      "ZOX-0000229",
      "Molnupiravir",
      "CVD-0016509",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(C)C(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc\\c(=N\\O)[nH]c1=O",
      "329.309"
    ],
    [
      "ZOX-0000230",
      "MAT-POS-3ccb8ef6-1",
      "CVD-0016619",
      "Dose-Response Complete.",
      "nan",
      "2.99",
      "7.61",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2CNC[C@@H](C(=O)Nc3cncc4ccccc34)c2c1",
      "337.81"
    ],
    [
      "ZOX-0000231",
      "BEN-BAS-c2bc0d80-7",
      "CVD-0014161",
      "Dose-Response Complete.",
      "nan",
      "1.79",
      "4.47",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CN1C(=O)N(C(=O)C11CCOc2ccc(Cl)cc12)c1cncc2ccccc12",
      "393.83"
    ],
    [
      "ZOX-0000232",
      "EDJ-MED-9e38fd34-1",
      "CVD-0015343",
      "Dose-Response Complete.",
      "nan",
      "2.92",
      "5.46",
      "44.5",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC1(C(=O)Nc2cncc3ccccc23)C(=O)Nc2ccc(Cl)cc12",
      "351.79"
    ],
    [
      "ZOX-0000233",
      "EDG-MED-ba1ac7b9-9",
      "CVD-0015596",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2OCCC(CC(=O)N3CCCCC3c3nc[nH]n3)(C(=O)Nc3cncc4ccccc34)c2c1",
      "531.01"
    ],
    [
      "ZOX-0000234",
      "EDG-MED-5d232de5-5",
      "CVD-0015362",
      "Dose-Response Complete.",
      "nan",
      "2.47",
      "6.5",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CN1CC[C@H](C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc12",
      "351.83"
    ],
    [
      "ZOX-0000235",
      "JNK-IN-8",
      "(E)-3-(4-(dimethylamino)but-2-enamido)-N-(3-methyl-4-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      "1.53",
      "Focus Forming Assay",
      "nan",
      "CC1=C(C=CC(=C1)NC(=O)C2=CC(=CC=C2)NC(=O)C=CCN(C)C)NC3=NC=CC(=N3)C4=CN=CC=C4",
      "507.6"
    ],
    [
      "ZOX-0000236",
      "LY3214996",
      "6,6-dimethyl-2-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)-5-(2-morpholinoethyl)-5,6-dihydro-4H-thieno[2,3-c]pyrrol-4-one",
      "Initial antiviral complete. Not progressing further.",
      "10",
      ">10",
      "nan",
      "86",
      "Focus Forming Assay",
      "nan",
      "CC1(C2=C(C=C(S2)C3=NC(=NC=C3)NC4=CC=NN4C)C(=O)N1CCN5CCOCC5)C",
      "453.6"
    ],
    [
      "ZOX-0000237",
      "ALP-POS-477dc5b7-5",
      "CVD-0013215",
      "Dose-Response Complete.",
      "nan",
      "2.83",
      "6.77",
      "94.6",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2OCCC3(CCCN(C3=O)c3cncc4ccccc34)c2c1",
      "378.86"
    ],
    [
      "ZOX-0000238",
      "MAT-POS-96f51285-6",
      "CVD-0016875",
      "Initial antiviral complete. Not progressing further.",
      "0.03",
      ">0.03",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COc1ccc2cncc(NC(=O)C3CCNc4cc(Cl)c(Cl)cc34)c2c1",
      "402.28"
    ],
    [
      "ZOX-0000239",
      "ALP-UNI-8d415491-5",
      "CVD-0016486",
      "Dose-Response Complete.",
      "100",
      ">100",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CS(=O)(=O)c1ccc2cncc(NC(=O)C3CCNc4cc(Cl)c(Cl)cc34)c2c1",
      "450.33"
    ],
    [
      "ZOX-0000240",
      "MAT-POS-a5ef2d74-2",
      "CVD-0016992",
      "Dose-Response Complete.",
      "nan",
      "1.95",
      "5.45",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COC1(CCOc2ccc(Cl)cc12)C(=O)Nc1cncc2ccc(F)cc12",
      "386.81"
    ],
    [
      "ZOX-0000241",
      "MAT-POS-dd3ad2b5-3",
      "CVD-0016467",
      "Dose-Response Complete.",
      "10",
      ">10",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "NC(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "380.83"
    ],
    [
      "ZOX-0000242",
      "ALP-UNI-8d415491-2",
      "CVD-0016483",
      "Dose-Response Complete.",
      "nan",
      "4.17",
      "11.3",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cc2NCCC(C(=O)Nc3cncc4CCCCc34)c2cc1Cl",
      "376.28"
    ],
    [
      "ZOX-0000243",
      "MIC-UNK-91acba05-3",
      "CVD-0013558",
      "Dose-Response Complete.",
      "nan",
      "3.52",
      "4.76",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2c(c1)C(CCS2(=O)=O)C(=O)Nc1cncc2ccccc12",
      "386.85"
    ],
    [
      "ZOX-0000244",
      "MAT-POS-96f51285-1",
      "CVD-0016870",
      "Dose-Response Complete.",
      "nan",
      "1.35",
      "2.61",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COc1ccc2cncc(NC(=O)C3(CCOc4ccc(Cl)cc34)OC)c2c1",
      "398.84"
    ],
    [
      "ZOX-0000245",
      "JIN-POS-6dc588a4-22",
      "CVD-0016572",
      "Initial antiviral complete. Not progressing further.",
      "0.33",
      ">0.33",
      "nan",
      "43.1",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cccc(CC(=O)Nc2cncc3sccc23)c1",
      "302.78"
    ],
    [
      "ZOX-0000246",
      "MAT-POS-dd3ad2b5-4",
      "CVD-0016468",
      "Dose-Response Complete.",
      "nan",
      "3.64",
      "14.6",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CS(=O)(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "415.89"
    ],
    [
      "ZOX-0000247",
      "MAT-POS-96f51285-2",
      "CVD-0016871",
      "Dose-Response Complete.",
      "nan",
      "3.14",
      "3.75",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COC1(CCOc2ccc(Cl)cc12)C(=O)Nc1cncc2ccc(cc12)S(C)(=O)=O",
      "446.9"
    ],
    [
      "ZOX-0000248",
      "MAT-POS-dd3ad2b5-5",
      "CVD-0016469",
      "Dose-Response Complete.",
      "nan",
      "7.91",
      "16.3",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CNC(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "394.86"
    ],
    [
      "ZOX-0000249",
      "MAT-POS-96f51285-3",
      "CVD-0016872",
      "Initial antiviral complete. Not progressing further.",
      "1",
      ">1",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COc1ccc2cncc(NC(=O)C3CCOc4cc(F)c(Cl)cc34)c2c1",
      "386.81"
    ],
    [
      "ZOX-0000250",
      "MAT-POS-dd3ad2b5-2",
      "CVD-0016466",
      "Dose-Response Complete.",
      "nan",
      "4.6",
      ">10",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "379.84"
    ],
    [
      "ZOX-0000251",
      "MAT-POS-96f51285-5",
      "CVD-0016874",
      "Dose-Response Complete.",
      "nan",
      "4.04",
      "13.2",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Fc1ccc2cncc(NC(=O)C3CCOc4cc(F)c(Cl)cc34)c2c1",
      "374.77"
    ],
    [
      "ZOX-0000252",
      "MAT-POS-993cdc78-1",
      "CVD-0016690",
      "Dose-Response Complete.",
      "nan",
      "1.02",
      "1.15",
      "77.9",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CO[C@@]1(CCOc2cc(F)c(Cl)cc12)C(=O)Nc1cncc2ccccc12",
      "386.81"
    ],
    [
      "ZOX-0000253",
      "ALP-UNI-8d415491-6",
      "CVD-0016487",
      "Dose-Response Complete.",
      "nan",
      "3.26",
      "17",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Fc1ccc2cncc(NC(=O)C3CCNc4cc(Cl)c(Cl)cc34)c2c1",
      "390.24"
    ],
    [
      "ZOX-0000254",
      "ALP-POS-fe871b40-16",
      "CVD-0015858",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1cc2NC(=O)CC(C(=O)Nc3cncc4ccccc34)c2cc1Cl",
      "386.23"
    ],
    [
      "ZOX-0000255",
      "MAT-POS-4223bc15-4",
      "CVD-0016899",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COCCS(=O)(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "459.95"
    ],
    [
      "ZOX-0000256",
      "MAT-POS-4223bc15-25",
      "CVD-0016918",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "NC(=O)CN1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "394.86"
    ],
    [
      "ZOX-0000257",
      "EDJ-MED-611d11e7-4",
      "CVD-0016452",
      "In progress.",
      "nan",
      "nan",
      "nan",
      "40.1",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CO[C@]1(CCOc2ccc(Cl)cc12)C(=O)Nc1cncc2ccc(F)cc12",
      "386.81"
    ],
    [
      "ZOX-0000258",
      "MAT-POS-4223bc15-6",
      "CVD-0016901",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CCS(=O)(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "429.92"
    ],
    [
      "ZOX-0000259",
      "MAT-POS-4223bc15-23",
      "CVD-0016916",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CNC(=O)CN1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "408.89"
    ],
    [
      "ZOX-0000260",
      "MAT-POS-ec6d90b7-6",
      "CVD-0017144",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COc1ccc2cncc(NC(=O)[C@H]3CCNc4cc(Cl)c(Cl)cc34)c2c1",
      "402.28"
    ],
    [
      "ZOX-0000261",
      "MAT-POS-4223bc15-11",
      "CVD-0016906",
      "In progress.",
      "nan",
      "nan",
      "nan",
      "91.5",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CC1CCN(C1)S(=O)(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "485"
    ],
    [
      "ZOX-0000262",
      "MAT-POS-4223bc15-9",
      "CVD-0017253",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "O[C@@H]1CCC[C@H]1S(=O)(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "485.98"
    ],
    [
      "ZOX-0000263",
      "MAT-POS-4223bc15-2",
      "CVD-0016897",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CN(C)S(=O)(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "444.93"
    ],
    [
      "ZOX-0000264",
      "MAT-POS-4223bc15-12",
      "CVD-0016907",
      "In progress.",
      "nan",
      "nan",
      "nan",
      "94.1",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2CN(CC(C(=O)Nc3cncc4ccccc34)c2c1)S(=O)(=O)CC1(CCC1)C#N",
      "494.99"
    ],
    [
      "ZOX-0000265",
      "MIC-UNK-91acba05-1",
      "CVD-0013556",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2C(=O)NCC(C(=O)Nc3cncc4ccccc34)c2c1",
      "351.79"
    ],
    [
      "ZOX-0000266",
      "MAT-POS-4223bc15-3",
      "CVD-0016898",
      "In progress.",
      "nan",
      "nan",
      "nan",
      "> 82.6",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Clc1ccc2CN(CC(C(=O)Nc3cncc4ccccc34)c2c1)S(=O)(=O)C1CC1",
      "441.93"
    ],
    [
      "ZOX-0000267",
      "MAT-POS-4223bc15-31",
      "CVD-0016924",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Cn1ncc(n1)S(=O)(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "482.94"
    ],
    [
      "ZOX-0000268",
      "RAL-THA-6e4c80cf-1",
      "CVD-0016844",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "COC(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "395.84"
    ],
    [
      "ZOX-0000269",
      "MAT-POS-4223bc15-41",
      "CVD-0016934",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Cn1cncc1C(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "445.91"
    ],
    [
      "ZOX-0000270",
      "MAT-POS-4223bc15-18",
      "CVD-0016913",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CN(C)C(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "408.89"
    ],
    [
      "ZOX-0000271",
      "MAT-POS-4223bc15-40",
      "CVD-0016933",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Cn1nccc1C(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "445.91"
    ],
    [
      "ZOX-0000272",
      "MAT-POS-4223bc15-1",
      "CVD-0016896",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "CNS(=O)(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "430.91"
    ],
    [
      "ZOX-0000273",
      "MAT-POS-4223bc15-39",
      "CVD-0016932",
      "In progress.",
      "nan",
      "nan",
      "nan",
      ">100",
      "Focus Forming Assay",
      "Direct Acting Antiviral",
      "Cc1nocc1C(=O)N1CC(C(=O)Nc2cncc3ccccc23)c2cc(Cl)ccc2C1",
      "446.89"
    ]
  ]
}